BlackRock's Quiet Accumulation in Hensoldt Meets a Market That Won't Cooperate

BlackRock has nudged its stake in Hensoldt higher, lifting its aggregate position to 4.93% from 4.80%, according to a voting-rights disclosure published Thursday. The threshold was crossed on Wednesday. The move lands just ahead of the defence group's capital markets day in London on 10 November 2026, and it offers a useful counterpoint to a share price that has spent the week moving in the opposite direction.

The stock closed Friday at €77.78, down 3.8%, as a global selloff in AI and semiconductor names spilled into the DAX and soured sentiment across the German market. Hensoldt had already come under pressure a day earlier, when it was dragged down by Rheinmetall's fresh guidance cut despite posting strong nine-month figures and raising its own full-year outlook.

A demand base that speaks for itself

The operating numbers Hensoldt released Thursday give the BlackRock position some substance. Order intake climbed 76.7% to €3.564 billion in the first nine months of 2026, pushing the order backlog to €10.4 billion. Revenue rose 21.3% to €1.863 billion over the same stretch, while adjusted EBITDA advanced 33.0% to €281 million.

Management also lifted its 2026 revenue guidance to roughly €2.8 billion and pinned the adjusted EBITDA margin at around 19.0%. The book-to-bill ratio is expected to land at the top end of the previously guided range of roughly 1.5x to 2.0x.

The gap between order growth and revenue growth is the number that matters most here. A 77% surge in intake against a 21% rise in sales is the signature of a company still converting backlog into billings — and the test of whether the profitability targets hold is how quickly that conversion happens.

Two houses, two verdicts

Analysts came away from the results with their ratings intact but their conclusions far apart. JPMorgan kept Hensoldt at "Neutral" with a €100.0 price target on Thursday, while Jefferies reaffirmed its "Buy" call and a €98 target the same day. Jefferies analyst Ben Brown pointed to revenue and adjusted EBITDA beating consensus estimates. Neither house changed its stance; no upgrade or downgrade accompanied the notes.

That split — one neutral, one bullish — frames the debate heading into the London event. The capital markets day now becomes the next scheduled moment for investors to weigh demand, revenue and earnings as a single story rather than three separate data points.

For BlackRock, the timing is straightforward: a larger position documented the day before the results, ahead of a guidance raise, and against a share price that has been falling on sector-wide news rather than company-specific weakness. Whether that proves prescient depends on how convincingly Hensoldt turns its swelling order book into profit at the margin it has promised.